Subscribe to stay informed!
Chesterbrook specialty biopharmaceutical developer Auxilium Pharmaceuticals Inc. will no longer chase an inversion-inspired merger with Canada’s QLT Inc. now that Endo International, whose…
Endo International said Sept. 30 the firm reached master settlement agreements with several law firms representing leading plantiffs to resolve claims over vaginal mesh products…
Endo International has delivered a proposal to acquire all outstanding shares of Auxilium Pharmaceuticals, a move that would give Auxilium shareholders immediate cash value and…
Endo International plc announced Aug. 6 it completed the acquisition of DAVA Pharmaceuticals, Inc., a privately-held company specializing in generic pharmaceuticals.
The purchase price…
Endo International plc is reporting second quarter 2014 revenues of $719 million – up 1 percent over the 2013 $712 million figure.
“Endo delivered strong performance…
Endo International plc, with headquarters in Malvern and Dublin, Ireland, has just acquired Grupo Farmaceutico Somar, a leading, privately owned specialty pharmaceuticals company based in…
After leaving Endo Pharmaceuticals to lead a new research and development company, the former senior vice president of discovery and early development for the Malvern…
Pharmaceutical developer and manufacturer Endo International, which is headquartered in Malvern, agreed to swallow up generic drug maker DAVA Pharmaceuticals, and a spoonful of “meaningful…
Shareholders of Endo Health Solutions, Inc. of Malvern recently approved the acquisition of Paladin Labs, Inc. of Montreal, Canada.
Paladin is an international specialty pharmaceutical…
While Malvern based Endo Pharmaceuticals, Inc. has been successful marketing branded products to help people live healthier lives, its marketing practices – which stepped outside the…
Before we send you to this site, please subscribe to our daily newsletter.